**Author details**

Gowthami Mahendran1,2 and Margaret A. Schwarz1,2,3\*

1 Harper Cancer Research Institute, United States

2 Department of Chemistry and Biochemistry, University of Notre Dame, United States

3 Departments of Pediatrics and Anatomy, Cell Biology and Physiology, Indiana University, South Bend, Indiana, United States

\*Address all correspondence to: schwarma@iu.edu

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

## **References**

[1] Grant RP. The embryology of ventricular flow pathways in man. Circulation. 1962;**25**:756-779

[2] Krishnan A, Samtani R, Dhanantwari P, Lee E, Yamada S, Shiota K, et al. A detailed comparison of mouse and human cardiac development. Pediatric Research. 2014;**76**(6):500-507

[3] Dhanantwari P, Lee E, Krishnan A, Samtani R, Yamada S, Anderson S, et al. Human cardiac development in the first trimester: A high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas. Circulation. 2009;**120**(4):343-351

[4] Tan CMJ, Lewandowski AJ. The transitional heart: From early embryonic and fetal development to neonatal life. Fetal Diagnosis and Therapy. 2020;**47**(5):373-386

[5] Zhang W, Chen H, Qu X, Chang CP, Shou W. Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC). American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2013;**163C**(3):144-156

[6] Sedmera D, Pexieder T, Hu N, Clark EB. A quantitative study of the ventricular myoarchitecture in the stage 21-29 chick embryo following decreased loading. European Journal of Morphology. 1998;**36**(2):105-119

[7] Samsa LA, Yang B, Liu J. Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation. American Journal of Medical Genetics.

Part C, Seminars in Medical Genetics. 2013;**163C**(3):157-168

[8] Keren A, Billingham ME, Popp RL. Echocardiographic recognition and implications of ventricular hypertrophic trabeculations and aberrant bands. Circulation. 1984;**70**(5):836-842

[9] Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal right ventricular dimensions. Heart. 2006;**92**(Suppl 1):i2-i13

[10] Kruithof BP, Kruithof-De-Julio M, Poelmann RE, Gittenberger-De-Groot AC, Gaussin V, Goumans MJ. Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFbeta2. The International Journal of Developmental Biology. 2013;**57**(11-12):853-863

[11] Wengrofsky P, Armenia C, Oleszak F, Kupferstein E, Rednam C, Mitre CA, et al. Left ventricular trabeculation and noncompaction cardiomyopathy: A review. EC Clinical and Experimental Anatomy. 2019;**2**(6):267-283

[12] Vaidya VR, Lyle M, Miranda WR, Farwati M, Isath A, Patlolla SH, et al. Long-term survival of patients with left ventricular noncompaction. Journal of the American Heart Association. 2021;**10**(2):e015563

[13] Goud A, Padmanabhan S. A rare form of cardiomyopathy: Left ventricular non-compaction cardiomyopathy. Journal of Community Hospital Internal Medicine Perspectives. 2016;**6**(1):29888

[14] Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/ noncompaction and association with

additional cardiac abnormalities and neuromuscular disorders. The American Journal of Cardiology. 2002;**90**(8):899-902

[15] Towbin JA. Left ventricular noncompaction: A new form of heart failure. Heart Failure Clinics. 2010;**6**(4):453-469 viii

[16] Towbin JA, Jefferies JL. Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circulation Research. 2017;**121**(7):838-854

[17] St-Pierre G, Steinberg C, Dubois M, Senechal M. What the cardiologist should know about mitochondrial cardiomyopathy? The Canadian Journal of Cardiology. 2019;**35**(2):221-224

[18] Greenwell AA, Gopal K, Ussher JR. Myocardial energy metabolism in nonischemic cardiomyopathy. Frontiers in Physiology. 2020;**11**:570421

[19] Guclu A, Knaapen P, Harms HJ, Parbhudayal RY, Michels M, Lammertsma AA, et al. Disease stagedependent changes in cardiac contractile performance and oxygen utilization underlie reduced myocardial efficiency in human inherited hypertrophic cardiomyopathy. Circulation: Cardiovascular Imaging. May 2017;**10**(5):e005604. DOI: 10.1161/ CIRCIMAGING.116.005604

[20] Taanman JW. The mitochondrial genome: Structure, transcription, translation and replication. Biochimica et Biophysica Acta. 1999;**1410**(2):103-123

[21] Saada A, Bar-Meir M, Belaiche C, Miller C, Elpeleg O. Evaluation of enzymatic assays and compounds affecting ATP production in mitochondrial respiratory chain complex I deficiency. Analytical Biochemistry. 2004;**335**(1):66-72

[22] Tuppen HA, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochimica et Biophysica Acta. 2010;**1797**(2):113-128

[23] Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, et al. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion. 2012;**12**(1):77-85

[24] Winter SC, Buist NR. Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. American Heart Journal. 2000;**139**(2 Pt 3):S63-S69

[25] McCormick EM, Muraresku CC, Falk MJ. Mitochondrial genomics: A complex field now coming of age. Current Genetic Medicine Reports. 2018;**6**(2):52-61

[26] Seppet EK, Eimre M, Anmann T, Seppet E, Peet N, Kaambre T, et al. Intracellular energetic units in healthy and diseased hearts. Experimental and Clinical Cardiology. 2005;**10**(3):173-183

[27] Reynen K, Bachmann K, Singer H. Spongy myocardium. Cardiology. 1997;**88**(6):601-602

[28] Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: Persistence of isolated myocardial sinusoids. The American Journal of Cardiology. 1984;**53**(11):1733-1734

[29] Lipshultz SE, Law YM, Asante-Korang A, Austin ED, Dipchand AI, Everitt MD, et al. Cardiomyopathy in children: Classification and diagnosis: A

scientific statement from the American Heart Association. Circulation. 2019;**140**(1):e9-e68

[30] Aung N, Doimo S, Ricci F, Sanghvi MM, Pedrosa C, Woodbridge SP, et al. Prognostic significance of left ventricular noncompaction: Systematic review and meta-analysis of observational studies. Circulation: Cardiovascular Imaging. Jan 2020;**13**(1):e009712. DOI: 10.1161/ CIRCIMAGING.119.009712

[31] Finsterer J, Stollberger C, Schubert B. Acquired left ventricular hypertrabeculation/noncompaction in mitochondriopathy. Cardiology. 2004;**102**(4):228-230

[32] Franz WM, Muller OJ, Katus HA. Cardiomyopathies: From genetics to the prospect of treatment. Lancet. 2001;**358**(9293):1627-1637

[33] Abbasi Y, Jabbari J, Jabbari R, Yang RQ, Risgaard B, Kober L, et al. The pathogenicity of genetic variants previously associated with left ventricular non-compaction. Molecular Genetics & Genomic Medicine. 2016;**4**(2):135-142

[34] Mazzarotto F, Hawley MH, Beltrami M, Beekman L, de Marvao A, McGurk KA, et al. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies. Genetics in Medicine. 2021;**23**(5):856-864

[35] Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, et al. EFNS guidelines on the molecular diagnosis of mitochondrial disorders. European Journal of Neurology. 2009;**16**(12):1255-1264

[36] Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, Neish SR,

et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004;**114**(4):925-931

[37] Kokoszka JE, Waymire KG, Flierl A, Sweeney KM, Angelin A, MacGregor GR, et al. Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction. Biochimica et Biophysica Acta. 2016;**1857**(8):1203-1212

[38] Finsterer J, Obermann I, Milvay E. Diagnostic yield of the lactate stress test in 160 patients with suspected respiratory chain disorder. Metabolic Brain Disease. 2000;**15**(3):163-171

[39] Jaksch M, Hofmann S, Kaufhold P, Obermaier-Kusser B, Zierz S, Gerbitz KD. A novel combination of mitochondrial tRNA and ND1 gene mutations in a syndrome with MELAS, cardiomyopathy, and diabetes mellitus. Human Mutation. 1996;**7**(4):358-360

[40] Finsterer J, Bittner R, Bodingbauer M, Eichberger H, Stollberger C, Blazek G. Complex mitochondriopathy associated with 4 mtDNA transitions. European Neurology. 2000;**44**(1):37-41

[41] Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, et al. Clinical characterization of left ventricular noncompaction in children: A relatively common form of cardiomyopathy. Circulation. 2003;**108**(21):2672-2678

[42] Ware SM, El-Hassan N, Kahler SG, Zhang Q, Ma YW, Miller E, et al. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. Journal of Medical Genetics. 2009;**46**(5):308-314

[43] Perucca-Lostanlen D, Narbonne H, Hernandez JB, Staccini P, Saunieres A, Paquis-Flucklinger V, et al. Mitochondrial DNA variations in patients with maternally inherited diabetes and deafness syndrome. Biochemical and Biophysical Research Communications. 2000;**277**(3):771-775

[44] Udeoji DU, Philip KJ, Morrissey RP, Phan A, Schwarz ER. Left ventricular noncompaction cardiomyopathy: Updated review. Therapeutic Advances in Cardiovascular Disease. 2013;**7**(5):260-273

[45] Morales-Arraez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, et al. Correction to: The MELD score is superior to the Maddrey discriminant function score to predict short-term mortality in alcohol-associated hepatitis: A global study. American Journal of Gastroenterology. 2022;**117**(5):818

[46] Cincinnati Children's. Available from: https://www.cincinnatichildrens. org/service/c/cardiomyopathy/types/ left-ventricular-non-compactioncardiomyopathy [Accessed: 12 August]

[47] Bennett CE, Freudenberger R. The current approach to diagnosis and management of left ventricular noncompaction cardiomyopathy: Review of the literature. Cardiology Research and Practice. 2016;**2016**:5172308

[48] Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: A step towards classification as a distinct cardiomyopathy. Heart. 2001;**86**(6):666-671

[49] Tian T, Liu Y, Gao L, Wang J, Sun K, Zou Y, et al. Isolated left ventricular noncompaction: Clinical profile and

prognosis in 106 adult patients. Heart and Vessels. 2014;**29**(5):645-652

[50] Agarwal A, Khandheria BK, Paterick TE, Treiber SC, Bush M, Tajik AJ. Left ventricular noncompaction in patients with bicuspid aortic valve. Journal of the American Society of Echocardiography. 2013;**26**(11):1306-1313

[51] Borresen MF, Blixenkrone-Moller E, Kock TO, Sillesen AS, Vogg ROB, Pihl CA, et al. Prevalence of left ventricular noncompaction in newborns. Circulation: Cardiovascular Imaging. 2022;**15**(6):e014159

[52] Ross SB, Barratt A, Semsarian C. Time to reconsider the diagnosis of "left ventricular noncompaction" in adults? Heart, Lung & Circulation. 2022;**31**(3):301-303

[53] Gleeson TG, Mwangi I, Horgan SJ, Cradock A, Fitzpatrick P, Murray JG. Steady-state free-precession (SSFP) cine MRI in distinguishing normal and bicuspid aortic valves. Journal of Magnetic Resonance Imaging. 2008;**28**(4):873-878

[54] Paluszkiewicz J, Milting H, Kaluzna-Oleksy M, Pyda M, Janus M, Korperich H, et al. Left ventricular non-compaction cardiomyopathystill more questions than answers. Journal of Clinical Medicine. 16 Jul 2022;**11**(14):4135. DOI: 10.3390/ jcm11144135

[55] Prevention Genetics. Available from: https://www.preventiongenetics. com/testInfo?val=Left-Ventricular-Noncompaction-%28LVNC%29-Panel [Accessed August 12]

[56] Jackson MJ, Schaefer JA, Johnson MA, Morris AA, Turnbull DM, Bindoff LA. Presentation and clinical

investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain. 1995;**118**(Pt 2):339-357

[57] Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy: Pathophysiology, diagnosis, and management. Texas Heart Institute Journal. 2013;**40**(4):385-394

[58] Kimura M, Kawano K, Yaoita H, Kure S. Successful treatment of an infant with left ventricular noncompaction presenting with fatal ventricular arrhythmia treated with cardiac resynchronization therapy and an implantable cardioverter defibrillator. Case Reports in Cardiology. 2018;**2018**:1-5

[59] Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;**82**(2):507-513

[60] Lofiego C, Biagini E, Ferlito M, Pasquale F, Rocchi G, Perugini E, et al. Paradoxical contributions of noncompacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction. The American Journal of Cardiology. 2006;**97**(5):738-741

[61] Tamborini G, Pepi M, Celeste F, Muratori M, Susini F, Maltagliati A, et al. Incidence and characteristics of left ventricular false tendons and trabeculations in the normal and pathologic heart by second harmonic echocardiography. Journal of the American Society of Echocardiography. 2004;**17**(4):367-374

[62] Cevik C, Stainback RF. Isolated left ventricular noncompaction in a 90-yearold man. Texas Heart Institute Journal. 2012;**39**(2):255-257

[63] Alehan D. Clinical features of isolated left ventricular noncompaction in children. International Journal of Cardiology. 2004;**97**(2):233-237

[64] Stollberger C, Blazek G, Winkler-Dworak M, Finsterer J. Sex differences in left ventricular noncompaction in patients with and without neuromuscular disorders. Revista Española de Cardiología. 2008;**61**(2):130-136

[65] Miller EM, Hinton RB, Czosek R, Lorts A, Parrott A, Shikany AR, et al. Genetic testing in pediatric left ventricular noncompaction. Circulation: Cardiovascular Genetics. Dec 2017;**10**(6):e001735. DOI: 10.1161/ CIRCGENETICS.117.001735

[66] Lin YN, Wang YQ, Yu Y, Cao Q, Wang F, Chen SY. Left ventricular noncompaction cardiomyopathy: A case report and literature review. International Journal of Clinical and Experimental Medicine. 2014;**7**(12):5130-5133

[67] Tian J, Uddin A, Akhrass P. Left ventricular noncompaction: A rare case of nonischemic cardiomyopathy. Case Reports in Cardiology. 2019;**2019**:5637638

[68] Burke A, Mont E, Kutys R, Virmani R. Left ventricular noncompaction: A pathological study of 14 cases. Human Pathology. 2005;**36**(4):403-411

[69] Toader D, Paraschiv A, Tudorascu P, Tudorascu D, Bataiosu C, Balseanu A. Left ventricular noncompaction-a rare cause of triad: Heart failure, ventricular arrhythmias, and systemic embolic events: A case report. Journal of Medical Case Reports. 2021;**15**(1):316

[70] Loria V, Colizzi C, Vaccarella M, Franceschi F, Aspromonte N. Left ventricular noncompaction: Cause or consequence of myocardial disease? A case report and literature review. Cardiology. 2019;**143**(3-4):100-104

[71] Ayesha B, Ahmed R, Gomceli U, Manrique C, Nicu M, Chilimuri S. A case of isolated left ventricular non-compaction cardiomyopathy in a HIV patient presenting with acute heart failure. Cardiology Research. 2019;**10**(4):236-240

[72] Bath AS, Aggarwal S, Gupta V, Kalavakunta JK. A case of left ventricular noncompaction presenting as atrial fibrillation. Cureus. 2019;**11**(3):e4309

[73] Kalavakunta JK, Tokala H, Gosavi A, Gupta V. Left ventricular noncompaction and myocardial fibrosis: A case report. International Archives of Medicine. 2010;**3**:20

[74] Shieh JT. Implications of genetic testing in noncompaction/ hypertrabeculation. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2013;**163C**(3):206-211

[75] Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;**117**(22):2893-2901

[76] Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001;**103**(9):1256-1263

[77] Shou W, Aghdasi B, Armstrong DL, Guo Q, Bao S, Charng MJ, et al. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 1998;**391**(6666):489-492

[78] Luxan G, Casanova JC, Martinez-Poveda B, Prados B, D'Amato G, MacGrogan D, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nature Medicine. 2013;**19**(2):193-201

[79] Hoedemaekers YM, Cohen-Overbeek TE, Frohn-Mulder IM, Dooijes D, Majoor-Krakauer DF. Prenatal ultrasound diagnosis of MYH7 non-compaction cardiomyopathy. Ultrasound in Obstetrics & Gynecology. 2013;**41**(3):336-339

[80] Frustaci A, De Luca A, Guida V, Biagini T, Mazza T, Gaudio C, et al. Novel alpha-actin gene mutation p.(Ala21Val) causing familial hypertrophic cardiomyopathy, myocardial noncompaction, and transmural crypts. Clinical-pathologic correlation. Journal of the American Heart Association. 10 Feb 2018;**7**(4):e008068. DOI: 10.1161/ JAHA.117.008068

[81] Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, Rupp S, et al. Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovascular Research. 2010;**86**(3):452-460

[82] Liu Z, Shan H, Huang J, Li N, Hou C, Pu J. A novel lamin A/C gene missense mutation (445 V > E) in immunoglobulin-like fold associated with left ventricular non-compaction. Europace. 2016;**18**(4):617-622

[83] Xing Y, Ichida F, Matsuoka T, Isobe T, Ikemoto Y, Higaki T, et al. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Molecular Genetics and Metabolism. 2006;**88**(1):71-77

[84] Ma L, Vaz FM, Gu Z, Wanders RJ, Greenberg ML. The human TAZ gene

complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome. The Journal of Biological Chemistry. 2004;**279**(43):44394-44399

[85] Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2004;**44**(9):1903-1910

[86] Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genetics. 1997;**16**(4):379-382

[87] Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;**406**(6798):906-910

[88] Milano A, Vermeer AM, Lodder EM, Barc J, Verkerk AO, Postma AV, et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. Journal of the American College of Cardiology. 2014;**64**(8):745-756

[89] Shan L, Makita N, Xing Y, Watanabe S, Futatani T, Ye F, et al. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia. Molecular Genetics and Metabolism. 2008;**93**(4):468-474

[90] Gifford CA, Ranade SS, Samarakoon R, Salunga HT, de Soysa TY, Huang Y, et al. Oligogenic inheritance of a human heart disease involving a genetic modifier. Science. 2019;**364**(6443):865-870

[91] Chen H, Zhang W, Sun X, Yoshimoto M, Chen Z, Zhu W, et al. Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. Development. 2013;**140**(9):1946-1957

[92] Hirono K, Saito K, Munkhsaikhan U, Xu F, Wang C, Lu L, et al. Familial left ventricular non-compaction is associated with a rare p.V407I variant in bone morphogenetic protein 10. Circulation Journal. 2019;**83**(8):1737-1746

[93] Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. Journal of the American College of Cardiology. 2003;**42**(11):2014-2027

[94] Schultze-Berndt A, Kuhnisch J, Herbst C, Seidel F, Al-Wakeel-Marquard N, Dartsch J, et al. Reduced systolic function and not genetic variants determine outcome in pediatric and adult left ventricular noncompaction cardiomyopathy. Frontiers in Pediatrics. 2021;**9**:722926

[95] Armel TZ, Leinwand LA. Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 2009;**106**(15):6291-6296

[96] Arbustini E, Favalli V, Narula N, Serio A, Grasso M. Left ventricular noncompaction: A distinct genetic cardiomyopathy? Journal of the American College of Cardiology. 2016;**68**(9):949-966

[97] Monserrat L, Hermida-Prieto M, Fernandez X, Rodriguez I, Dumont C, Cazon L, et al. Mutation in the alphacardiac actin gene associated with apical hypertrophic cardiomyopathy,

left ventricular non-compaction, and septal defects. European Heart Journal. 2007;**28**(16):1953-1961

[98] Parent JJ, Towbin JA, Jefferies JL. Left ventricular noncompaction in a family with lamin A/C gene mutation. Texas Heart Institute Journal. 2015;**42**(1):73-76

[99] Mogensen J, Kruse TA, Borglum AD. Assignment of the human cardiac troponin I gene (TNNI3) to chromosome 19q13.4 by radiation hybrid mapping. Cytogenetics and Cell Genetics. 1997;**79**(3-4):272-273

[100] Muntoni F, Bonne G, Goldfarb LG, Mercuri E, Piercy RJ, Burke M, et al. Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain. 2006;**129**(Pt 5):1260-1268

[101] Dautant A, Meier T, Hahn A, Tribouillard-Tanvier D, di Rago JP, Kucharczyk R. ATP synthase diseases of mitochondrial genetic origin. Frontiers in Physiology. 2018;**9**:329

[102] Finsterer J, Stollberger C, Steger C, Cozzarini W. Complete heart block associated with noncompaction, nailpatella syndrome, and mitochondrial myopathy. Journal of Electrocardiology. 2007;**40**(4):352-354

[103] Dorner A, Giessen S, Gaub R, Grosse Siestrup H, Schwimmbeck PL, Hetzer R, et al. An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy. European Journal of Heart Failure. 2006;**8**(1):81-89

[104] Arndt AK, Schafer S, Drenckhahn JD, Sabeh MK, Plovie ER, Caliebe A, et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of

PRDM16 as a cause of cardiomyopathy. American Journal of Human Genetics. 2013;**93**(1):67-77

[105] Bolling MC, Pas HH, de Visser M, Aronica E, Pfendner EG, van den Berg MP, et al. PLEC1 mutations underlie adult-onset dilated cardiomyopathy in epidermolysis bullosa simplex with muscular dystrophy. The Journal of Investigative Dermatology. 2010;**130**(4):1178-1181

[106] Girolami F, Iascone M, Tomberli B, Bardi S, Benelli M, Marseglia G, et al. Novel alpha-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: A massively parallel sequencing study. Circulation. Cardiovascular Genetics. 2014;**7**(6):741-750

[107] Lang T, Yu L, Tu Q, Jiang J, Chen Z, Xin Y, et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36. Genomics. 2000;**70**(2):258-263

[108] Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 2003;**299**(5611):1410-1413

[109] Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. The Journal of Clinical Investigation. 2003;**111**(6):869-876

[110] Dellefave LM, Pytel P, Mewborn S, Mora B, Guris DL, Fedson S, et al. Sarcomere mutations in cardiomyopathy with left

ventricular hypertrabeculation. Circulation. Cardiovascular Genetics. 2009;**2**(5):442-449

[111] Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, et al. MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet Journal of Rare Diseases. 2016;**11**(1):91

[112] Hasegawa H, Komuro I. Mutations in sarcomere protein genes as a cause of heart failure. Nihon Rinsho. 2007;**65**(Suppl 4):267-272

[113] D'Amato G, Luxan G, de la Pompa JL. Notch signalling in ventricular chamber development and cardiomyopathy. The FEBS Journal. 2016;**283**(23):4223-4237

[114] Finsterer J, Stollberger C, Fazio G. Neuromuscular disorders in left ventricular hypertrabeculation/ noncompaction. Current Pharmaceutical Design. 2010;**16**(26):2895-2904

[115] Tang S, Batra A, Zhang Y, Ebenroth ES, Huang T. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion. 2010;**10**(4):350-357

[116] Liu S, Bai Y, Huang J, Zhao H, Zhang X, Hu S, et al. Do mitochondria contribute to left ventricular noncompaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy. Molecular Genetics and Metabolism. 2013;**109**(1):100-106

[117] Bleyl SB, Mumford BR, Brown-Harrison MC, Pagotto LT, Carey JC, Pysher TJ, et al. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. American Journal of Medical Genetics. 1997;**72**(3):257-265

[118] Saric A, Andreau K, Armand AS, Moller IM, Petit PX. Barth syndrome: From mitochondrial dysfunctions associated with aberrant production of reactive oxygen species to pluripotent stem cell studies. Frontiers in Genetics. 2015;**6**:359

[119] Karkucinska-Wieckowska A, Trubicka J, Werner B, Kokoszynska K, Pajdowska M, Pronicki M, et al. Left ventricular noncompaction (LVNC) and low mitochondrial membrane potential are specific for Barth syndrome. Journal of Inherited Metabolic Disease. 2013;**36**(6):929-937

[120] Hsieh YT, Tu HF, Yang MH, Chen YF, Lan XY, Huang CL, et al. Mitochondrial genome and its regulator TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic effectors. Cell Death & Disease. 2021;**12**(11):961

[121] Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochimica et Biophysica Acta. 2012;**1817**(10):1833-1838

[122] Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. Journal of Biochemistry. 2011;**149**(3):241-251

[123] Dorn GW 2nd. Mitochondrial dynamism and heart disease: Changing shape and shaping change. EMBO Molecular Medicine. 2015;**7**(7):865-877

[124] Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial ironsulphur protein deficiency in Friedreich ataxia. Nature Genetics. 1997;**17**(2):215-217

[125] Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. The ADP/

ATP translocator is not essential for the mitochondrial permeability transition pore. Nature. 2004;**427**(6973):461-465

[126] Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. The Journal of Cell Biology. 2003;**160**(2):189-200

[127] Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurologica Scandinavica. 2007;**116**(1):1-14

[128] Shanske S, Pancrudo J, Kaufmann P, Engelstad K, Jhung S, Lu J, et al. Varying loads of the mitochondrial DNA A3243G mutation in different tissues: Implications for diagnosis. American Journal of Medical Genetics. Part A. 2004;**130A**(2):134-137

[129] Finsterer J, Stollberger C, Wegmann R, Janssen LA. Acquired left ventricular hypertrabeculation/ noncompaction in myotonic dystrophy type 1. International Journal of Cardiology. 2009;**137**(3):310-313

[130] de Andrade PB, Rubi B, Frigerio F, van den Ouweland JM, Maassen JA, Maechler P. Diabetesassociated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia. 2006;**49**(8):1816-1826

[131] Mkaouar-Rebai E, Kammoun F, Chamkha I, Kammoun N, Hsairi I, Triki C, et al. A de novo mutation in the adenosine triphosphatase (ATPase) 8 gene in a patient with mitochondrial disorder. Journal of Child Neurology. 2010;**25**(6):770-775

[132] Jonckheere AI, Hogeveen M, Nijtmans LG, van den Brand MA, Janssen AJ, Diepstra JH, et al. A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. Journal of Medical Genetics. 2008;**45**(3):129-133
